UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-K/A
(AMENDMENT No. 1)
ý
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended September 28, 2018
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Transition Period From              To             
Commission File Number: 001-32431
DOLBYBLACKA01A21.JPG
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Delaware
 
90-0199783
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
1275 Market Street
San Francisco, CA
94103-1410
(415) 558-0200
(Address of principal executive offices)
(Zip Code)
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Class A common stock, $0.001 par value
The New York Stock Exchange
(Title of class)
(Name of each exchange on which registered)
Securities registered pursuant to Section 12(g) of the Act:
Class B common stock, $0.001 par value
 
(Title of class)
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes    ý      No    ¨
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes    ¨      No    ý
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes    ý      No    ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes    ý      No    ¨
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (Section 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨
Indicate by a check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer    ý
  
Accelerated filer    ¨
Non-accelerated filer    ¨  
  
Smaller reporting company    ¨
 
 
Emerging growth company  ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes    ¨      No    ý
The aggregate market value of the voting common equity held by non-affiliates of the registrant as of March 30, 2018 was $3.4 billion . This calculation excludes the shares of Class A and Class B common stock held by executive officers, directors and stockholders whose ownership exceeds 5% of the combined shares of Class A and Class B common stock outstanding at March 30, 2018 . This calculation does not reflect a determination that such persons are affiliates for any other purposes. On October 26, 2018 , the registrant had 64,002,056 shares of Class A common stock, par value $0.001 per share, and 39,261,035 shares of Class B common stock, par value $0.001 per share, outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the registrant’s Definitive Proxy Statement, filed on December 19, 2018 with the Commission pursuant to Regulation 14A in connection with the registrant’s 2019 Annual Meeting of Stockholders, are incorporated by reference into Part III of this Report. Except with respect to information specifically incorporated by reference in this Form 10-K/A, the Definitive Proxy Statement is not deemed to be filed as part of this Form 10-K/A.


EXPLANATORY NOTE

This Amendment No. 1 on Form 10-K/A (the “Form 10-K/A” or the “Amendment”) amends the Annual Report of Dolby Laboratories, Inc. (the “Company”) on Form 10-K for the fiscal year ended September 28, 2018, as filed with the Securities and Exchange Commission (the “SEC”) on November 15, 2018 (the “Original Report”).

This Amendment is being filed solely to replace the Consent of Independent Registered Public Accounting Firm (the “Consent”) included in the Original Report as Exhibit 23.1, with the corrected Consent. Due to an administrative oversight, an incorrect version of the Consent was inadvertently included in the Original Report. The Company possessed a correct, manually signed copy of the Consent from KPMG LLP (“KPMG”) when the Original Report was filed with the SEC.

Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended, this Form 10-K/A contains new certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, which are attached hereto. Item 15 of this Amendment reflects a new consent of KPMG. Except as stated above, there are no other changes to the Original Report.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
 
1.
Financial Statements: See “Index to Consolidated Financial Statements” in Part II, Item 8 of the Original Report.
2.
Financial Statement Schedules: Financial statement schedules have been omitted as the information required is inapplicable or the information is presented in the consolidated financial statements and related notes.
3.
Exhibits: The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Amendment.


INDEX TO EXHIBITS
Exhibit
Number
Description
Incorporated by Reference Herein
Form
Date
2.1*
Registration Statement on Form S-1
(No. 333-120614), Amendment No. 1
December 30, 2004
3.1
Registration Statement on Form S-1 (No. 333-120614), Amendment No. 2
January 19, 2005
3.2
Quarterly Report on Form 10-Q
April 30, 2009
4.1
Registration Statement on Form S-1
(No. 333-120614), Amendment No. 1
December 30, 2004
4.2
Registration Statement on Form 8-A
January 25, 2006
10.1*
Registration Statement on Form S-1
(No. 333-120614)
November 19, 2004
10.2*
Quarterly Report on Form 10-Q
February 6, 2013
10.3*
Current Report on Form 8-K
February 9, 2017
10.4*
Annual Report on Form 10-K
November 16, 2017
10.5*
Registration Statement on Form S-1
(No. 333-120614)
November 19, 2004
10.6*
Quarterly Report on Form 10-Q
February 2, 2017
10.7*
Quarterly Report on Form 10-Q
February 2, 2017
10.8*
Quarterly Report on Form 10-Q
February 2, 2017
10.9*
Quarterly Report on Form 10-Q
February 2, 2017
10.10*
Annual Report on Form 10-K
November 19, 2009
10.11*
Quarterly Report on Form 10-Q
August 8, 2012
10.12*
Current Report on Form 8-K
December 11, 2015
10.13*
Current Report on Form 8-K
November 15, 2017
10.14*
Quarterly Report on Form 10-Q
April 30, 2009
10.15*
Quarterly Report on Form 10-Q
February 6, 2013
10.16*
Quarterly Report on Form 10-Q
May 10, 2011
10.17*
Quarterly Report on Form 10-Q
May 8, 2012
10.18*
Quarterly Report on Form 10-Q
January 29, 2014
10.19*
Quarterly Report on Form 10-Q
February 8, 2006
10.20*
Quarterly Report on Form 10-Q
May 4, 2006
10.21*
Quarterly Report on Form 10-Q
July 30, 2014
10.22*
Quarterly Report on Form 10-Q
February 8, 2006
10.23*
Quarterly Report on Form 10-Q
July 30, 2014
10.24*
Quarterly Report on Form 10-Q
February 8, 2006
10.25*
Quarterly Report on Form 10-Q
July 30, 2014
10.26*
Annual Report on Form 10-K
November 15, 2013
10.27*
Quarterly Report on Form 10-Q
August 8, 2012
10.28*
Quarterly Report on Form 10-Q
August 1, 2018
21.1+
 
 
23.1+
 
 
24.1
Power of Attorney (incorporated by reference from the signature page of this Original Report)
31.1+
31.2+
32.1‡
101.INS‡ XBRL Instance Document
101.SCH‡ XBRL Taxonomy Extension Schema Document
101.CAL‡ XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF‡ XBRL Extension Definition
101.LAB‡ XBRL Taxonomy Extension Label Linkbase Document
101.PRE‡ XBRL Taxonomy Extension Presentation Linkbase Document
+    Filed herewith.
*    Denotes a management contract or compensatory plan or arrangement.
‡    Furnished herewith.

3

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: April 1, 2019
 
DOLBY LABORATORIES, INC.
By:
/ S /   LEWIS CHEW
 
Lewis Chew
 
Executive Vice President and Chief Financial Officer
 
(Principal Financial Officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
SIGNATURE
  
TITLE
DATE
 
 
 
 
/S/    KEVIN J. YEAMAN
 
President, Chief Executive Officer and Director
(Principal Executive Officer)
April 1, 2019
Kevin J. Yeaman
  
 
 
 
 
 
/S/    LEWIS CHEW
 
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
April 1, 2019
Lewis Chew
  
 
 
 
 
 
/S/    RYAN NICHOLSON
 
Vice President, Corporate Controller
(Principal Accounting Officer)
April 1, 2019
Ryan Nicholson
 
 
 
 
 
 

4
Dolby Laboratories (NYSE:DLB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Dolby Laboratories Charts.
Dolby Laboratories (NYSE:DLB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Dolby Laboratories Charts.